News

Dr. Varsha Atuluru Joins Ankle & Foot Centers of America

ATLANTA, GA / ACCESS Newswire / December 8, 2025 / Fellowship-trained in advanced reconstructive techniques, Dr. Varsha Atuluru brings comprehensive,…

2 weeks ago

MIRAU Capital Management Named Exclusive Financial Planning Partner for Power Up Nursing’s National Network

New "Financial First Aid for Nurses" Campaign Helps Nurses Treat Their Money Like They Treat Their Patients LAKE WORTH, FLORIDA…

2 weeks ago

CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting

SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 8, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company…

2 weeks ago

Europe’s Hospitals Can’t Cut Off Hacked Vendors Fast Enough, New Cyber Report Warns

Black Book Research's Europe Cybersecurity in Healthcare 2026 finds only 13% of providers have tested kill-switches for critical vendors and…

2 weeks ago

Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network

Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom…

2 weeks ago

Avant Brands Fully Repays $9.5M Secured Convertible Debenture

KELOWNA, BC / ACCESS Newswire / December 8, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading…

2 weeks ago

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in…

2 weeks ago

Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray

Ra’anana, Israel, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing…

2 weeks ago

Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer

Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, underscoring the potential for broad…

2 weeks ago

rYojbaba Subsidiary Sakai Seikotsuin Serves as an Official Trainer at the 2025 Taipei Wake Open

FUKUOKA, Japan, Dec. 08, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) ("rYojbaba" or the "Company"), a Japanese labor…

2 weeks ago